<span item_type="fundamental" item_id="467b04b38f10c5e08b7343ec6e8a1475" counter_id="ST/US/HIT" env="prod"></span><span item_type="announcement" item_id="547274206341438721" env="prod"></span><p>Revenue: As of FY2025 Q2, the actual value is USD 9.314 M.</p><p>EPS: As of FY2025 Q2, the actual value is USD 0.01.</p><p>EBIT: As of FY2025 Q2, the actual value is USD 833.27 K.</p><p></p><h3>Segment Revenue</h3><ul><li><strong>Revenues from Underwriting Modeling (ICE)</strong>: $2,090,576 for the three months ended June 30, 2025, compared to $1,639,105 for the same period in 2024, representing a 27.5% increase.<span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/2019505/000121390025073712/ea0251952-10q_health.htm"></span></li><li><strong>Revenues from Fees</strong>: $7,223,273 for the three months ended June 30, 2025, compared to $3,363,385 for the same period in 2024, representing a 114.8% increase.<span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/2019505/000121390025073712/ea0251952-10q_health.htm"></span></li></ul><h3>Operational Metrics</h3><ul><li><strong>Net Income</strong>: $630,631 for the three months ended June 30, 2025, compared to $338,007 for the same period in 2024.<span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/2019505/000121390025073712/ea0251952-10q_health.htm"></span></li><li><strong>Gross Profit</strong>: $6,309,870 for the three months ended June 30, 2025, compared to $4,027,763 for the same period in 2024.<span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/2019505/000121390025073712/ea0251952-10q_health.htm"></span></li><li><strong>Operating Expenses</strong>: $5,584,800 for the three months ended June 30, 2025, compared to $3,492,827 for the same period in 2024.<span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/2019505/000121390025073712/ea0251952-10q_health.htm"></span></li></ul><h3>Cash Flow</h3><ul><li><strong>Net Cash Provided by Operating Activities</strong>: $2,008,629 for the six months ended June 30, 2025, compared to $586,329 for the same period in 2024.<span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/2019505/000121390025073712/ea0251952-10q_health.htm"></span></li></ul><h3>Unique Metrics</h3><ul><li><strong>Adjusted EBITDA</strong>: $1,569,016 for the three months ended June 30, 2025, compared to $669,723 for the same period in 2024.<span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/2019505/000121390025073712/ea0251952-10q_health.htm"></span></li></ul><h3>Future Outlook and Strategy</h3><ul><li><strong>Core Business Focus</strong>: Health In Tech, Inc. plans to continue investing in technology and innovation to drive advancements in automation and enhance operational efficiency across all aspects of its business.<span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/2019505/000121390025073712/ea0251952-10q_health.htm"></span></li><li><strong>Non-Core Business</strong>: The company is exploring partnerships and collaborations with various insurance carriers to expand its portfolio of products and services.<span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/2019505/000121390025073712/ea0251952-10q_health.htm"></span></li></ul>

Health In Tech | 10-Q: FY2025 Q2 Revenue: USD 9.314 M